• 12:54 - 16:14
Dr. Roger McFillin | The Chemical Imbalance Myth, Predatory Psychiatry, & Mood Management Industry
Clinical Trial Manipulation and the Suppression of Akathisia Data
Dr. Peter Bregan’s research into the discovery process of lawsuits against Eli Lilly revealed that pharmaceutical companies suppressed data regarding dangerous side effects during SSRI trials. Approximately 38% of trial participants experienced a "stimulation effect," ranging from agitation to akathisia, a neurological condition that induces suicidal impulses. To hide these effects from the FDA and outperform placebos, researchers administered benzodiazepines like Xanax to sedate trial participants.